---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-056751"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2025-12-12T23:59:59+00:00"
generated_at: "2026-05-16T13:23:01.093070+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# GRI Bio closes $8.0M public offering of common stock and Series F warrants

## Summary
- Offering of 10,666,667 shares (or equivalents) plus Series F warrants to buy same number at $0.75/share.
- Gross proceeds $8.0M; H.C. Wainwright acted as exclusive placement agent.
- Series F warrants exercisable immediately at $0.75, expire in five years; potential additional $8.0M if fully cash-exercised.
- Proceeds to fund product development, working capital, and general corporate purposes.
- Post-offering stockholders' equity exceeds $2.5 million, addressing Nasdaq continued listing requirement.

## SEC filing metadata
- accession: 0001628280-25-056751
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2025-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000162828025056751/0001628280-25-056751-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000162828025056751/val-20251212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-056751
- JSON: https://secwatch.observer/filing/0001628280-25-056751.json
- Plain text: https://secwatch.observer/filing/0001628280-25-056751.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.